- Home
- ABEO vs BLDE Comparison
ABEO vs BLDE Comparison
Compare ABEO & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- BLDE
- Stock Information
- Founded
- ABEO N/A
- BLDE 2014
- Country
- ABEO United States
- BLDE United States
- Employees
- ABEO N/A
- BLDE N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- BLDE Aerospace
- Sector
- ABEO Health Care
- BLDE Consumer Discretionary
- Exchange
- ABEO Nasdaq
- BLDE Nasdaq
- Market Cap
- ABEO 277.6M
- BLDE 276.7M
- IPO Year
- ABEO 1980
- BLDE N/A
- Fundamental
- Price
- ABEO $6.41
- BLDE $3.52
- Analyst Decision
- ABEO Strong Buy
- BLDE
- Analyst Count
- ABEO 3
- BLDE 0
- Target Price
- ABEO $18.00
- BLDE N/A
- AVG Volume (30 Days)
- ABEO 290.2K
- BLDE 527.4K
- Earning Date
- ABEO 11-11-2024
- BLDE 11-06-2024
- Dividend Yield
- ABEO N/A
- BLDE N/A
- EPS Growth
- ABEO N/A
- BLDE N/A
- EPS
- ABEO N/A
- BLDE N/A
- Revenue
- ABEO N/A
- BLDE $238,379,000.00
- Revenue This Year
- ABEO N/A
- BLDE $12.14
- Revenue Next Year
- ABEO $7,097.06
- BLDE $11.35
- P/E Ratio
- ABEO N/A
- BLDE N/A
- Revenue Growth
- ABEO 147.52
- BLDE 25.39
- 52 Week Low
- ABEO $3.05
- BLDE $2.06
- 52 Week High
- ABEO $9.01
- BLDE $4.25
- Technical
- Relative Strength Index (RSI)
- ABEO 61.15
- BLDE 62.70
- Support Level
- ABEO $6.39
- BLDE $3.37
- Resistance Level
- ABEO $6.74
- BLDE $3.60
- Average True Range (ATR)
- ABEO 0.31
- BLDE 0.15
- MACD
- ABEO 0.02
- BLDE 0.05
- Stochastic Oscillator
- ABEO 68.57
- BLDE 89.87
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.